去甲肾上腺素输注联合目标导向液体治疗对肾移植术后移植肾功能延迟恢复影响的多中心随机对照试验研究方案
本研究为多中心、随机、单盲、双臂平行对照试验,旨在评估去甲肾上腺素输注联合目标导向液体治疗对肾移植患者移植肾功能恢复的疗效。患者随机分为对照组(常规液体管理)和干预组(去甲肾上腺素输注联合目标导向液体治疗)。主要目的是探讨该联合策略能否降低移植肾功能延迟恢复的发生率。
要点
- 移植肾功能延迟恢复是肾移植术后常见早期并发症,主要源于缺血再灌注损伤和边缘供体使用。
- 目标导向液体治疗在危重症中显示改善预后,但在肾移植中的疗效尚存争议。
- 本试验为多中心随机单盲平行对照设计,比较去甲肾上腺素联合目标导向液体治疗与常规液体管理。
核心结论
- 本研究旨在探讨去甲肾上腺素输注联合目标导向液体治疗降低肾移植患者移植肾功能延迟恢复发生率的潜在疗效。
研究设计与样本
- 多中心、随机、单盲、双臂平行组、对照试验,比较常规液体管理与去甲肾上腺素输注联合目标导向液体治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease presents a formidable challenge to global healthcare systems. With ongoing advancements in surgical techniques, kidney transplantation has emerged as a principal therapeutic modality for individuals afflicted with end-stage renal disease, markedly enhancing their long-term prognosis and overall quality of life postoperatively. Nevertheless, the occurrence of delayed graft function represents a prevalent early complication following kidney transplantations, mainly stemming from the ischemia-reperfusion injury incurred by the transplanted kidneys and the utilization of extended criteria donor organs. The manifestation of delayed graft function can precipitate primary allograft nonfunction, acute rejection episodes, and potentially fatal outcomes. Vigilant attention to perioperative fluid management emerges as a cornerstone in mitigating the risk of delayed graft function. Recent strides in Goal-directed fluid therapy have garnered substantial attention within critical care contexts, with empirical evidence underscoring its favorable impact on postoperative outcomes in critically ill cohorts. However, the efficacy of Goal-directed fluid therapy specifically in the context of kidney transplantation remains a subject of ongoing debate and scrutiny. Hence, the imperative arises to investigate potential strategies aimed at attenuating the incidence of delayed graft function in this patient demographic. METHODS: A multicenter, randomized, single-blind, two-arm parallel-group, controlled trial will be undertaken to assess the efficacy of norepinephrine in conjunction with Goal-directed fluid therapy on graft function recovery among individuals slated for kidney transplantations. Patients will be allocated randomly to either a control or intervention arm, wherein conventional fluid management or the administration of norepinephrine infusion combined with Goal-directed fluid therapy will be administered, respectively. DISCUSSION: The primary objective of this study is to investigate the potential efficacy of norepinephrine infusion in conjunction with goal-directed fluid therapy in mitigating the occurrence of delayed graft function among individuals undergoing kidney transplantations. The findings of this investigation have the potential to advance the field of perioperative care in kidney transplantations by providing insights into optimized management strategies. TRIAL REGISTRATION: ClinicalTrials.gov NCT06367205. Registered on April 16, 2024.
引用
- Shi M, Zhang Y, Ding X, et al. The effects of norepinephrine infusion combined with goal-directed fluid therapy on delayed graft function in patients undergoing kidney transplantations: study protocol for a multicenter randomized controlled trial. Trials. 2026. PMID: 42687184. doi:10.1186/s13063-026-09972-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。